Despite extensive literature on the impact of genetic variants in APOE, GBA, MAPT, and SNCA on cognitive progression in PD, large studies with prospective follow-up from the time of PD diagnosis are scarce and many studies track patients solely from a clinical environment. Here, MAPT is linked to Parkinson disease.